BioSpace News Archive

Job Trends

Study shows MD Anderson-developed drug effective in overcoming ibrutinib resistance in mantle cell lymphoma

A study at The University of Texas MD Anderson Cancer Center demonstrated how a small molecule drug discovered at the institution may help overcome resistance to treatment with ibrutinib in patients with mantle cell lymphoma.

May 9, 2019
·
3 min read
Business

Assertio Therapeutics Announces First-quarter 2019 Financial Results

Assertio Therapeutics, Inc. reported financial results for the quarter ended March 31, 2019, and provided an update on its business performance and strategic initiatives.

May 9, 2019
·
10 min read
New Study Demonstrates Safety and Effectiveness of the MiniMed(TM) 640G System Reducing Hypoglycemia Compared with Insulin Pump Therapy Without CGM in Type 1 Diabetes

Medtronic plc announced the publication of the SMILE study in The Lancet Diabetes & Endocrinology.

May 9, 2019
·
4 min read
Business

Expedeon Reports First Quarter 2019 Financial Results

Expedeon AG reported results for the first quarter ended March 31, 2019.

May 9, 2019
·
3 min read
Drug Development

Polyphor Temporarily Halts Enrollment in the Phase III Studies of Murepavadin for the Treatment of Patients With Nosocomial Pneumonia

Polyphor announced the decision to temporarily halt enrollment for the pivotal Phase III trials PRISM-MDR and PRISM-UDR evaluating murepavadin in patients with nosocomial pneumonia due to higher than expected acute kidney injury incidences in the murepavadin arm of the PRISM-MDR trial.

May 9, 2019
·
5 min read
Biotech Beach

Arcutis, Inc.'s ARQ-151 Development Program for Plaque Psoriasis

Arcutis, Inc. provided details on the ARQ-151 clinical development program for plaque psoriasis.

May 9, 2019
·
3 min read
Business

The Institute for Clinical and Economic Review (ICER) Will Now Leverage Data and Insights From IPD Analytics

The Institute for Clinical and Economic Review (ICER) has reached an agreement with IPD Analytics LLC (IPD) whereby ICER will leverage IPD’s data, expertise and assessments to advance their horizon scanning efforts across the pharmaceutical and biologic markets.

May 9, 2019
·
3 min read
Pharm Country

Merck’s Pneumococcal Vaccine for Babies Looks Good in Trial

Merck and Co. announced that its investigational 15-valent pneumococcal conjugate vaccine was “noninferior” to a currently available 13-valent pneumococcal conjugate vaccine in healthy babies 6 to 12 weeks of age.

May 9, 2019
·
3 min read
·
Mark Terry
Pharm Country

The Best of the Rest: A Roundup of Life Science Stories

Today has been marked by a wide range of life science and biopharma stories. Here’s a broader look at some of the top stories.

May 9, 2019
·
4 min read
·
Mark Terry
Medigene AG: Medigene participates at upcoming May and June 2019 conferences

Medigene AG announced its participation at the following upcoming scientific, business development and investor conferences

May 9, 2019
·
1 min read